...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD
【24h】

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

机译:调节性B细胞在健康供体的IgM记忆和过渡亚群中富集,但在慢性GVHD中缺乏

获取原文
获取原文并翻译 | 示例

摘要

A subset of regulatory B cells (Bregs) in mice negatively regulate T-cell immune responses through the secretion of regulatory cytokines such as IL-10 and direct cell-cell contact and have been linked to experimental models of autoimmunity, inflammation, and cancer. However, the regulatory function of Bregs in human disease is much less clear. Here we demonstrate that B cells with immunoregulatory properties are enriched within both the CD19+IgM+CD27+memory and CD19+CD24hiCD38hitransitional B-cell subsets in healthy human donors. Both subsets suppressed the proliferation and interferon-/production of CD3/CD28-stimulated autologous CD4+T cells in a dose-dependent manner, and both relied on IL-10 secretion as well as cell-cell contact, likely mediated through CD80 and CD86, to support their full suppressive function. Moreover, after allogeneic stem cell transplantation, Bregs from patients with chronic graft-versus-host disease (cGVHD) were less frequent and less likely to produce IL-10 than were Bregs from healthy donors and patients without cGVHD. These findings suggest that Bregs may be involved in the pathogenesis of cGVHD and support future investigation of regulatory B cell-based therapy in the treatment of this disease.
机译:小鼠中的调节性B细胞(Breg)的子集通过调节性细胞因子(例如IL-10)的分泌和直接的细胞与细胞的接触,负面调节T细胞的免疫反应,并已与自身免疫,炎症和癌症的实验模型相关联。但是,Bregs在人类疾病中的调节功能尚不清楚。在这里,我们证明了具有免疫调节特性的B细胞在健康人类供体的CD19 + IgM + CD27 +记忆和CD19 + CD24hiCD38hi过渡性B细胞亚群中都富集。这两个亚群均以剂量依赖的方式抑制了CD3 / CD28刺激的自体CD4 + T细胞的增殖和干扰素/产生,并且都依赖于IL-10分泌以及细胞间的接触,这可能是通过CD80和CD86介导的。 ,以支持其全部抑制功能。此外,同种异体干细胞移植后,患有慢性移植物抗宿主病(cGVHD)的患者的Breg较来自健康供体和无cGVHD的患者的Breg更为不频繁,更不可能产生IL-10。这些发现表明,Bregs可能参与cGVHD的发病机理,并支持将来基于调节性B细胞的疗法治疗该疾病的研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号